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INTRODUCTION
Osteoclasts are a member of the monocyte/
macrophage lineage and are formed by multiple cel-
lular fusions from their mononuclear precursors.
They play an important role in bone metabolism by
regulating bone resorption. Receptor activator of nu-
clear factor-κB ligand (RANKL) induces differentia-
tion into osteoclasts from myeloid precursors at vari-
ous intermediate stages as well as from well differen-
tiated tissue macrophages such as alveolar macro-
phages (1). One of the characteristic features of this
lineage is the presence of the phagocyte NADPH
oxidase (2-5). Superoxide anion (O2-) and related
reactive oxygen species (ROS) produced by the
phagocyte NADPH oxidase play a crucial role in
the process of killing ingested microorganisms
(6). The phagocyte NADPH oxidase consists of a
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membrane-integrated flavocytochrome b558, com-
posed of gp91phox and p22phox, and four cytosolic com-
ponents (p47phox, p67phox, p40phox, and Rac) that asso-
ciate with the flavocytochrome to form an active en-
zyme (6).
Recently, two families of gp91phox homologues
have been identified as potential sources of ROS :
NADPH oxidase (Nox) and dual oxidase (Duox)
families (7, 8). The Nox family comprises Nox1,
Nox2 (gp91phox), Nox3, Nox4, and Nox5. Nox1 is
also associated with the membrane-integrated pro-
tein p22phox and requires at least three additional co-
factors, Nox organizer 1 (NOXO1), Nox activator 1
(NOXA1), and Rac1 for the activation of the Nox1-
based oxidase system (7, 8). Nox1 is also able to
use the p47phox and p67phox subunits (9). Nox3 is a
p22phox -dependent enzyme and is constitutively inac-
tive, weakly active, or substantially active depending
on cell type (7, 8). NOXO1 enhances Nox3 activity.
However, the requirement for the other components
is still contradictory. Nox4 is also a p22phox - depend-
ent enzyme (10). According to our present knowl-
edge, Nox4 does not require cytosolic subunits.
These new enzymes show tissue- and cell type - spe-
cific distribution and are proposed to have distinct
functions (7, 8).
Osteoclasts attach to the surface of bone and se-
crete protons into an extracellular compartment be-
tween osteoclast and bone surface. The osteoclast
proton pump is essential for bone mineral solubili-
zation and digestion of organic bone matrix by acid
proteases (11). At the same time, ROS produced by
activated osteoclast are suggested to participate in
the complex process of bone resorption (2, 4). It has
also been suggested that ROS derived from osteo-
clast precursors are essential for osteoclast differ-
entiation (12). Osteoclasts express Nox2 in their ruf-
fled borders (5). Considering the origin of osteo-
clasts, it is conceivable that Nox2 may be an enzyme
responsible for the ROS-dependent differentiation
and bone-resorbing activities. However, it is known
that Nox2 knockout (Nox2-/-) mouse osteoclasts are
still able to produce O2- (13), and no bone abnor-
malities have been documented in Nox2-/- mice or in
patients with chronic granulomatous disease. These
observations could be explained at least in part by
the expression of Nox4 mRNA and protein in ma-
ture osteoclasts (13, 14) and Nox1 in osteoclast pre-
cursors (12). In fact, Nox4 was reported to be re-
sponsible for generation of O2- and formation of re-
sorption pits by osteoclasts (13, 14). A recent study
has suggest that Nox1 rather than Nox2 or Nox4 is
important for RANKL-initiated ROS production and
differentiation into osteoclasts (12). However, even
in the case of Nox1-/- mice, no bone abnormalities
have so far been reported (15, 16). Although there
may be an active compensatory mechanism for the
Nox system in the osteoclast lineage, it is still un-
clear whether Nox-derived ROS are essential for os-
teoclast differentiation.
In this study, using a mouse monocyte cell line
(RAW264.7), we examined the role of Nox homo-
logues in RANKL-induced differentiation into osteo-
clasts and bone-resorbing activity.
MATERIALS AND METHODS
1. Reagents
Recombinant mouse RANKL was prepared as de-
scribed previously (17). Histopaque-1077, naphthol
AS-MX phosphate, fast red violet LB salt, phorbol
12-myristate 13-acetate (PMA), and superoxide dis-
mutase (SOD) were obtained from Sigma Chemical
Co. (St. Louis, MO). Submicron synthesis calcium
phosphate thin film-coated disks were purchased
from BD Bioscience (Bedford, MA). The enhancer-
containing luminol-based detection system (Dio-
genes) was obtained from National Diagnostics (At-
lanta, GA). A rabbit anti-serum against human Nox2
(residues 536 -555) was a gift from Dr. Tsunawaki,
National Research Institute for Child Health and De-
velopment, Tokyo.
2. Culture of RAW264.7 (RAW) cells
RAW cells were maintained in Dulbecco’s modi-
fied Eagle’s medium (DMEM) containing 10%
heat-inactivated fetal calf serum (FCS ; Invitrogen,
Carlsbad, CA), 100 U/ml penicillin G, and 100 μg/
ml streptomycin at 37under 95%-air and 5%-CO2.
To stimulate differentiation of RAW cells into osteo-
clasts, they were cultured with RANKL (150 ng/ml)
in phenol red-free α -minimum essential medium (α -
MEM) containing 10% heat-inactivated FCS in 12-
well (1104 cells/well), 24 -well (0.5 -1104 cells/
well), 48-well (3103 cells/well), or 96-well (1103
cells/well) culture plates. A half volume of the
RANKL-containing medium was replaced with the
fresh medium every 3 days.
3. Real-time reverse transcriptase (RT)-PCR
Total RNA was extracted using an acid guanidium-
thiocyanate-phenol chloroform mixture (18). Levels
of Nox1, Nox2, Nox3, Nox4, p47phox, p67phox, p22phox,
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NOXO1, NOXA1, Rac1, Rac2, TRAP, cathepsin K,
ATPase (Atp6i), chloride channel 7 (ClC-7), nuclear
factor of activated T-cells, cytoplasmic 1 (NFATc1),
and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNAs were measured by quantitative
real-time reverse transcriptase (RT)-PCR. Specific
primer sets for Nox1 (ABI part No.Mm01340621_
g1), Nox2 (Mm00432774_m1), Nox3 (Mm01339126
_m1), Nox4 (Mm00479246_m1), p47phox (Mm
00447921_m1), p67phox (Mm00726636_s1), p22phox
(Mm00514478_m1), NOXO1 (Mm00546832_g1),
NOXA1 (Mm00549171_m1), Rac1 (Mm01201653_
mH), Rac2 (Mm00485472_m1), TRAP (Mm00475698
_m1), cathepsin K (Mm00484035_m1), Atp6i (Mm
00469395_g1), ClC-7 (Mm00442400_m1), NFATc1
(Mm00479445_m1), and GAPDH (Mm99999915_
g1) were designed using the Primer Express pro-
gram (Applied Biosystems, Foster City, CA). cDNA
was generated from 1 μg of total RNA with Multis-
cribe Reverse Transcriptase (Applied Biosystems)
using oligodT/hexamer primers. Real-time RT-
PCR was performed using the ABI 7500 (Applied
Biosystems). Data were normalized for the amount
of GAPDH mRNA.
4. Western blot analysis
Membrane proteins were prepared from RAW
cells and peritoneal macrophages from Nox2-/- mice
(provided by Mary C. Dinauer, Indiana University
School of Medicine, Indianapolis, IN, USA) (19) as
previously described (18), and amounts of Nox2 in
the membrane fractions were measured by im-
munoblot analysis using antiserum against the resi-
dues 536-555 of human Nox2 (20).
5. Tartrate resistant acid phosphatase (TRAP) stain
Cells were stained for TRAP activity as previously
described (17). Cells were fixed with 10% formalin
in phosphate-buffered saline at room temperature
for 15 min. They were quenched with a 1 : 1 (v/v)
mixture of ice cold acetone and ethanol. These cells
were incubated for 15 -60 min at 37with 0.1 M
acetate buffer (pH 5), containing 25 mM sodium tar-
trate, 0.01% naphthol AS-MX phosphate, and 0.06%
fast red violet LB salt, and then rinsed with water.
TRAP-positive multinucleated cells havingthree
nuclei were counted as osteoclasts under micro-
scopic observation.
6. Bone resorption assay
Bone-resorbing activity was assessed using sub-
micron synthesis calcium phosphate thin film-coated
disks. RAW cells were cultured with 150 ng/ml
RANKL for the indicated days on the calcium phos-
phate thin film-coated disks in 24-well culture plates.
After adherent cells were removed by washing with
5% sodium hypochlorite for 5 min, the disk was
washed with water and photographed. The area of
resorption pits on the disk was measured in 16 ran-
domly selected areas and analyzed with NIH im-
ageJ software (http : //rsb.info.nih.gov/ij/).
7. Measurement of O2-
The rate of O2- production by RAW cells and
RAW cell-derived osteoclasts was determined by
SOD-inhibitable chemiluminescence using an en-
hancer-containing luminol-based detection system
(Diogenes ; National Diagnostics). RAW cells were
left untreated or treated with 150 ng/ml RANKL for
5 days. These cells were incubated with the en-
hanced luminol-based substrate (50% of total reac-
tion volume) in Hank’s balanced salt solution
(HBSS) at 1105 cells/well in 96-well clear-bottom
white plates (Nunc Inc., Naperville, IL). Both spon-
taneous and 50 ng/ml PMA-stimulated changes in
chemiluminescence were measured in the presence
or absence of 20 μg/ml SOD with a microplate
reader (Wallac 1420 ARVOTMMX ; PerkinElmer,
Waltham, MA) and were expressed in arbitrary
units during 1-s readings recorded at 1-min inter-
vals over a time course of 30 min.
8. Small interfering RNA (siRNA)
A duplexed StealthTM siRNA designed against
p22phox (accession no. NM_007806) or p67phox (acces-
sion no. NM_010877) was purchased from Invitro-
gen. The sequences were as follows : p22phox siRNA,
5’-CCAGGUUAACCCAAUGCCAGUGACA-3’ (sense)
and 5’ -UGUCACUGGCAUUGGGUUAACCUGG-3’
(antisense) ; p67phox siRNA, 5’ -CCAUGGAGAGCA-
UCUGGAAGCAGAA-3’ (sense) and 5’ -UUCUGC-
UUCCAGAUGCUCUCCAUGG-3’ (antisense). RAW
cells were seeded at a density of 5105 cells/dish in
35-mm-diameter culture dishes or 1105 cells/well
in 24-well culture plates and transfected with con-
trol siRNA (Stealth RNAi negative control, Invitro-
gen), p22phox siRNA, or p67phox siRNA using Lipofec-
tamine RNAiMAX (Invitrogen) for 48 h according
to the manufacturer’s protocol. After transfection,
these cells were collected and cultured in 24- or 96-
well plates with 150 ng/ml RANKL in α -MEM sup-
plemented with 10% FCS for 5 days.
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RESULTS
1. Effects of RANKL treatment on mRNA expression
of Nox enzymes and their regulatory proteins in
RAW cells
As shown in Fig. 1, RAW cells constitutively ex-
pressed Nox2, p47phox, NOXO1, p67phox, p22phox, Rac1,
and Rac2 mRNAs. Small amounts of Nox1 (about
0.005% of Nox2 mRNA level) and Nox3 (about
0.001% of Nox2 mRNA level) mRNAs could be de-
tected, while RAW cells did not express Nox4 or
NOXA1 transcripts. RANKL treatment dramatically
decreased the Nox2 mRNA level to around 2% of the
original level within 3 days (Fig. 1A). This decline
was associated with the reduction of p47phox (Fig. 1
D) and p67phox (Fig. 1E) mRNA levels. In contrast,
RANKL inversely up-regulated expression of Nox1
about 8-fold (Fig. 1B). However, expression of its
organizer protein (NOXO1) mRNA was rather down-
regulated (Fig. 1F). Nox3 mRNA level gradually in-
creased after treatment with RANKL (Fig. 1C), but
its level was still around 10% of that of Nox1 mRNA
on day 5. We also confirmed that Nox4 transcript
was not detectable even after stimulation by RANKL
(data not shown).
2. Reduction of Nox2 protein in RAW cells after
treatment with RANKL
A rabbit anti-serum against human Nox2 (resi-
dues 536-555) was shown to recognized Nox2 pro-
tein, preferentially its unglycosylated form (20). To
confirm the specificity of the antiserum, membrane
proteins were prepared from peritoneal macrophages
of Nox2-/- mice and used as a negative control.
A B C
D E F
G H I
Fig. 1. Expression of mRNAs for Nox enzymes and their adaptor proteins in RANKL-treated RAW cells.
RAW cells were left untreated or treated with 150 ng/ml RANKL for the indicated days. A half volume of the medium was replaced
with the fresh medium every 3 days. (A-I) Total RNA was prepared from these cells, and mRNA levels of Nox1, Nox2, Nox3, p22phox,
p47phox, p67phox, NOXO1, Rac1, and Rac2 were measured by real - time RT-PCR. GAPDH mRNA level was used as an internal quantity
control. Values are meansSD in three independents experiments. aSignificantly different, compared with untreated control cells
(P0.05 by ANOVA and Scheffé’s test).
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Western blotting showed that the anti -Nox2 se-
rum mainly recognized 63-kDa protein and several
proteins with higher molecular weights, and these
proteins were absent in peritoneal macrophages
from Nox2 knockout mice (Fig. 2). Consistent with
the marked decline of Nox2 mRNA level, Nox2
protein level was substantially decreased in RAW
cell-derived osteoclasts.
3. RANKL- induced differentiation of RAW cells
into osteoclasts
After treatment with RANKL, RAW cells gradually
changed their shapes, and TRAP-positive, multinu-
cleated cells appeared on day 3 and constituted 70-
80% of total cells on day 5 (Fig. 3A). These cells ex-
hibited bone resorbing activity (Fig. 3A). We also
measured mRNA expression of genes associated
with osteoclastogenesis. Treatment of RAW cells
with RANKL up-regulated expression of TRAP (Fig.
3B), Cathepsin K (Fig. 3C), Atp6i (Fig. 3D), and
ClC-7 (Fig. 3E) mRNAs during the differentiation
into osteoclasts.
Fig. 2. RANKL-induced decline of Nox2 protein in RAW cells.
Membrane proteins were prepared from peritoneal macrophages
(M) from Nox2-/- mice, RAW cells, and RAW cell -derived osteo-
clasts, as previously described (18), and amounts of Nox2 in the
membrane proteins (2 μg protein per lane) were measured by
immunoblot analysis using antiserum against the residues 536-
555 of human Nox2 (20).
A B
C D E
Fig. 3. RANKL-induced differentiation of RAW cells into osteoclasts.
(A) RAW cells left untreated or treated with 150 ng/ml RANKL for 5 days were fixed and stained with TRAP on day 5 (upper panels).
RAW cells were cultured for 5 days on submicron synthesis calcium phosphate thin films in the presence or absence of 150 ng/ml
RANKL. After removal of the cells, the thin films were photographed using light microscopy (lower panels). Scale bars are 400 μm.
Levels of TRAP (B), Cathepsin K (C), Atp6i (D), and ClC-7 (E) mRNAs were measured by real - time RT-PCR using GAPDH mRNA
level as an internal quantity control. Values are meansSD of four independent experiments. aSignificantly different, compared with
untreated control cells (P0.05 by ANOVA and Scheffé’s test).
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4. O2- production by RAW cells and RAW cell-
derived osteoclasts
We also examined how RANKL treatment changed
O2- - producing capability in RAW cells. In associa-
tion with the striking changes in Nox homologue
expression, particularly with the marked decline of
Nox2 expression, spontaneous and PMA-stimulated
O2- production by RAW cell-derived osteoclasts de-
creased to about 8% and 3% of the respective con-
trol values (Figs. 4A and 4B).
5. Effects of knockdown of p22phox or p67phox in RAW
cells on osteoclast differentiation
No bone abnormalities have been documented in
Nox2-/- (13) and Nox1-/- mice (15, 16). Mutation in
the Nox3 gene has defect in otoconia morphogene-
sis, while no bone abnormalities have been docu-
mented in the mutant mice (21). RAW cells did not
express Nox4, but could differentiate into osteoclasts
in response to RANKL. These observations suggest
that there may be a flexible compensatory mecha-
nism among the Nox family to maintain ROS gen-
eration during osteoclast differentiation.
Using RAW cells, we examined whether Nox-de-
rived ROS were essential for osteoclast differentia-
tion. RAW cells expressed only p67phox as a Nox ac-
tivator and did not express Nox4. Therefore, it was
considered that knockdown of p67phox or p22phox ef-
fectively suppressed the O2- - producing capability of
Nox enzymes expressed in RAW cells. RAW cells
were treated with different concentrations (10-100
nM) of siRNA against p67phox or p22phox for 48 h. As
shown in Fig. 5, 50 nM p22phox siRNA (Fig. 5A) and
50 nM p67phox siRNA (Fig. 5B) knocked down re-
spective mRNA levels to30%, and consequently
PMA-stimulated O2- generation was decreased to
A B
Fig. 4. Changes in O2- production by RAW cells after treat-
ment with RANKL.
(A) After RAW cells were cultured with or without 150 ng/ml
RANKL for 5 days, chemiluminescence derived from spontaneous
or PMA-stimulated O2- production by these cells was continu-
ously monitored with an enhanced luminol -based substrate, Dio-
genes, in the presence or absence of 20 μg/ml SOD. (B) Each
value is meanSD (n=4) of the peak chemiluminescence values.
A B C D
E F
Fig. 5. Effects of p22phox or p67phox siRNA on differentiation of RAW cells into osteoclasts.
After RAW cells were transfected with 50 nM p22phox siRNA, 50 nM p67phox, or 50 nM control siRNA (Stealth RNAi negative control ;
Invitrogen), they were cultured with 150 ng/ml RANKL for 5 days. p22phox mRNA levels (A), p67phox mRNA levels (B), PMA-
stimulated O2- generation (C), TRAP-positive cells (D), bone resorption (E), and NFATc1 and TRAP mRNA levels (F) were meas-
ured as described in the legends to the above Figs. Scale bars are 400 μm. Each value represents meanSD of three independent
experiments. aSignificantly different, compared with control siRNA-treated cells (P0.05 by ANOVA and Scheffé’s test).
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30%, compared with those in control siRNA-treated
cells (Fig. 5C). When these cells were treated with
RANKL for 5 days, numbers of TRAP-positive, multi-
nucleated cells (Fig. 5D) and formation of resorption
pits (Fig. 5E) were significantly reduced, compared
with those of control siRNA-treated cells. In asso-
ciation with the impaired osteoclast formation,
knockdown of Nox enzymes resulted in the reduc-
tion of RANKL-stimulated mRNA expression of
NFATc1 as well as TRAP (Fig. 5F).
DISCUSSION
There are two crucial steps in osteoclast forma-
tion : commitment of progenitor cells to osteoclast
precursor cells, and fusion of mononuclear cells to
form TRAP-positive, multinucleated osteoclasts. The
activation of the receptor for RANKL (RANK) is a
key step in the differentiation of mature osteoclasts
during the late stage (22-24). The RANK activation
leads to the activation of distinct signaling cascades,
such as nuclear factor (NF) -κB and mitogen-acti-
vated protein kinases (MAPKs), including p38
MAPK, c-Jun N-terminal kinases, and extracellular
signal - regulated kinases, through several adaptor
proteins and cofactors (25). RANKL also stimulates
ROS generation, which has been suggested to be
crucial for the activation of the RANK-signaling cas-
cades leading to osteoclast differentiation (12). This
is supported by the observations that addition of ex-
ogenous hydrogen peroxide stimulates osteoclastic
bone resorption and cell motility (26). Alternatively,
antioxidants can block the RANKL-dependent sig-
naling (27, 28).
The most striking feature, observed during the
RANKL-induced differentiation of RAW cells, was
the marked reduction of Nox2 mRNA expression.
Inversely related to this reduction, RANKL up-regu-
lated Nox1 transcript expression. RANKL more
slowly up-regulated Nox3 transcript expression and
this roughly coincided with the appearance of TRAP-
positive, multinucleated cells in RAW cells. In as-
sociation with the marked down-regulation of Nox2
mRNA expression, the rate of spontaneous and
PMA-stimulated O2- production by RAW cell - de-
rived osteoclasts decreased to about 8% and 3% of
the respective control values, suggesting that the ter-
minal differentiation of a monocyte-macrophage line-
age cells into osteoclasts is associated with switch-
ing from a potent Nox2 -based oxidase system
in phagocytic cells to functionally different Nox
systems that produce much smaller, but probably
sufficient amounts of O2- to change intracellular sig-
nals and functions. We also examined mRNA ex-
pression of the CCAAT displacement protein gene
encoding a negative regulator for Nox2 gene tran-
scription; however, RANKL did not change the
mRNA level (data not shown). At present, the mo-
lecular mechanism for the Nox2 down-regulation
is unknown. However, the abundant expression of
Nox2 in osteoclasts, like in monocytes or macro-
phages, may be rather hazardous for bone health.
Estrogen deprivation (29), homocysteine (28), or in-
terferon γ(IFN-γ) (30) could activate osteoclast for-
mation through increased ROS generation and NF-
κB activation, which may contribute to osteoporosis
by increasing bone resorption. Stimulation of osteo-
clast activity through IFN-γ involves Nox2 up-regu-
lation (31). Thus, the decreased expression of Nox2
expression during osteoclast differentiation may be
relevant to the maintenance of bone homeostasis.
RAW cells expressed p22phox, two Nox organizer
subunits (p47phox and NOXO1), one Nox activator
(p67phox), and two small GTPases (Rac1 and Rac2).
RAW cells expressed a full set of components for
Nox2 activity. According to the present knowledge
on Nox1 enzymes and their regulatory proteins
(7, 8), Nox1 can use p67phox instead of NOXA1 (9).
Nox3 activity is facilitated by the presence of p47phox
and p67phox, NOXO1 and NOXA1, or NOXO1 alone
(32). RAW cells did not express Nox4. Nox5 is not
expressed in the mouse (7, 8). Thus, all Nox homo-
logues detected in RAW cells are thought to become
active enzymes. There are some difficulties in knock-
down experiments. Induction of osteoclast differen-
tiation with RANKL occurs at relatively low cell den-
sity; therefore, relatively higher concentrations of
siRNA were necessary to keep their efficacy during
3-5 days of the differentiation period, which some-
times damaged cells and nonspecifically inhibited
osteoclast formation. Therefore, to test whether ROS
derived from any types of Nox were essential for
osteoclast formation, we knocked down one target
mRNA that was designed to totally block Nox-de-
pendent ROS generation in RAW cells. Theoreti-
cally, it was expected that knockdown of p22phox
would substantially remove all Nox enzyme activi-
ties, and that p67phox siRNA would profoundly elimi-
nate the activities of Nox1, Nox2, and possibly Nox3.
In fact, introduction of p22phox or p67phox siRNA sig-
nificantly down-regulated O2- to30% of the con-
trol level on day 3. These siRNAs partially, but
significantly blocked osteoclast formation, which was
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confirmed again by appearance of TRAP-positive,
multinucleated cells, resorption pit formation, and
expression of genes encoding a crucial transcrip-
tion factor (NFATc1) and an osteoclast marker pro-
tein (TRAP). These results suggest that Nox-de-
rived ROS may, at least in part, facilitate osteoclast
differentiation.
The present study shows that RANKL stimulates
switching between Nox homologues during osteo-
clast differentiation, and suggests that Nox-derived
ROS may be essential for RANKL-induced osteo-
clast differentiation.
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